![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, April 25, 2014 7:54:41 PM
1. There is soon to be a contract for Amarantus to move in to a manufacturing facility coming up I'm surprised not many mentioned this unless I missed it somewhere
2. Amarantus CEO has his father presenting at a conference next week about Phenoguard which can be a new protein family (meaning an increased portfolio position like MANF) which would increase value of the company.
3. Another thing I liked was that BD will finish lympro and hand it off to another company to commercialize. Depending what company it is this could be a very huge catalyst for the stock.
4. If MANF is successful in Wolfram's Syndrome it could be branched to type I and type II diabetes.
There are too many good things to list so I just chose some to list!
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM